Startups
iBio, Inc.
Edit

iBio, Inc.

http://ibioinc.com/
Last activity: 02.05.2025
Active
Categories: DevelopmentFacilityHealthTechManufacturingMedTechPlatformProductProductionResearchService
At iBio, we’re enabling the next generation of biologics with the FastPharming® System for high-quality, eco-friendly recombinant protein production. A wide array of proteins can be efficiently expressed using our Nicotiana benthamiana plants, and readily scaled-up for high-volume production in our 130,000-square-foot FastPharming Facility in Bryan, Texas.

We’re putting these capabilities to work for our clients via an array of contract development and manufacturing services, as well as deploying them for the advancement of our own pipeline of therapeutics, vaccines, and products for research & bioprocessing applications. Plus, with our new Glycaneering™ Development Service, we have greater control over protein glycoforms, including the ability to remove fucose to create more potent monoclonal antibody therapeutics.

Our innovative, hard-working teams are combining our technologies and capabilities to address unmet medical needs in human health and veterinary medicine, while enabling our clients to advance their biopharmaceuticals and 3D-bioprinted/tissue-engineered products through the clinic and to market.
Website visits
8.8K /mo.
Mentions
75

Overview

Location
United States, Texas, College Station
Employees
51-200
Founded date
2008

Mentions in press and media 75

DateTitleDescription
Sign up to seeSign up to seeSign up to see
Dec 9, 2022iBio Announces Closing of $3.5 Million Underwritten Public Offering
Dec 7, 2022iBio Announces Pricing of $3.5 Million Underwritten Public OfferingBRYAN, Texas, Dec. 06, 2022 (GLOBE NEWSWIRE) -- iBio, Inc. IBIO ("iBio" or the "Company"), an AI-driven innovator of precision antibody immunotherapies, today announced the pricing of its previously announced underwritte...
Dec 6, 2022iBio Announces Pricing of $3.5 Million Underwritten Public Offering
Nov 4, 2022iBio Accelerates Transformation to AI-Powered BiotechiBio, an AI-driven innovator of precision antibody immunotherapies, announces it is seeking to divest its contract development and manufacturing organization (iBio CDMO, LLC) in order to complete its transformation into an antibody discover...
Jun 21, 20213 Houston companies named to semifinals of clean energy competitionThree Houston energy startups are in the running for the $100,000 cash prize in Cleantech.org's GS Beyond Energy Innovation Challenge. Amperon Holdings, Cemvita Factory, and Veloce Energy are among the competition's 24 semifinalis...
Jun 21, 2021Houston-Dallas high-speed train still not official but now it has a builderThe high-speed train between Houston and Dallas still needs an official sign-off before it happens, but a builder has been hired for when that day comes. Texas Central, the developers of the train, have signed a $16 billion contract with We...
Jun 21, 20213 Houston innovators to know this weekEditor's note: In this week's roundup of Houston innovators to know, I'm introducing you to three local innovators across industries — from startup and small business support to electric vehicles — recently making headlines i...
May 19, 2021Legal Issues Behind It, IBIO Stock May Be a Long Play For Risk-Tolerant InvestorsMay 19, 2021 4 min read This story originally appeared on MarketBeat iBio (NYSEAMERICAN:IBIO) was one of the more fascinating stocks at the onset of the Covid-19 pandemic. The company already possessed a proprietary system for producing pro...
May 12, 2021New Houston accelerator leader dives into first cohortEverything's bigger in Texas, but Kate Evinger is focused on zeroing in on a small group of startups to help them in a Texas-sized way. As director of gBETA Houston, Evinger says the program, which expanded to Houston in 2019, is geare...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In

FAQ about iBio, Inc.

When was iBio, Inc. founded?

iBio, Inc. was founded in 2008.

What has the press written about iBio, Inc.?

Parsers VC has collected 75 articles mentioning iBio, Inc., among them “iBio Announces Closing of $3.5 Million Underwritten Public Offering” (Dec 9, 2022) and “iBio Announces Pricing of $3.5 Million Underwritten Public Offering” (Dec 7, 2022).

Is iBio, Inc. still active?

Yes, iBio, Inc. is active; its latest activity on Parsers VC dates from May 2, 2025.